144 related articles for article (PubMed ID: 23546761)
21. Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.
Sartipy P; Björquist P
Stem Cells; 2011 May; 29(5):744-8. PubMed ID: 21433222
[TBL] [Abstract][Full Text] [Related]
22. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy P; Bjorquist P; Strehl R; Hyllner J
IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
[TBL] [Abstract][Full Text] [Related]
23. Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.
Shaheen N; Shiti A; Gepstein L
Clin Pharmacol Ther; 2017 Aug; 102(2):203-208. PubMed ID: 28718902
[TBL] [Abstract][Full Text] [Related]
24. Cardiomyocytes derived from human pluripotent stem cells for drug screening.
Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Pharmacol Ther; 2012 May; 134(2):180-8. PubMed ID: 22269465
[TBL] [Abstract][Full Text] [Related]
25. Can stem-cell-derived models revolutionize drug discovery?
Landgren H; Sartipy P
Expert Opin Drug Discov; 2014 Jan; 9(1):9-13. PubMed ID: 24308376
[TBL] [Abstract][Full Text] [Related]
26. Human pluripotent stem cells in drug discovery and predictive toxicology.
Laustriat D; Gide J; Peschanski M
Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
[TBL] [Abstract][Full Text] [Related]
27. Ca²⁺ channel activators reveal differential L-type Ca²⁺ channel pharmacology between native and stem cell-derived cardiomyocytes.
Kang J; Chen XL; Ji J; Lei Q; Rampe D
J Pharmacol Exp Ther; 2012 May; 341(2):510-7. PubMed ID: 22353878
[TBL] [Abstract][Full Text] [Related]
28. Discovering small molecules to control stem cell fate.
Andrews PD
Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
[TBL] [Abstract][Full Text] [Related]
29. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
30. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types.
Pal R; Totey S; Mamidi MK; Bhat VS; Totey S
Exp Biol Med (Maywood); 2009 Oct; 234(10):1230-43. PubMed ID: 19546356
[TBL] [Abstract][Full Text] [Related]
31. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
32. Stem cells. Diseases in a dish take off.
Vogel G
Science; 2010 Nov; 330(6008):1172-3. PubMed ID: 21109645
[No Abstract] [Full Text] [Related]
33. Protocols for cardiac differentiation of embryonic stem cells.
Pucéat M
Methods; 2008 Jun; 45(2):168-71. PubMed ID: 18593613
[TBL] [Abstract][Full Text] [Related]
34. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
Pal R; Mamidi MK; Das AK; Bhonde R
J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
[TBL] [Abstract][Full Text] [Related]
35. Human embryonic stem cells: current technologies and emerging industrial applications.
Améen C; Strehl R; Björquist P; Lindahl A; Hyllner J; Sartipy P
Crit Rev Oncol Hematol; 2008 Jan; 65(1):54-80. PubMed ID: 17689256
[TBL] [Abstract][Full Text] [Related]
36. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
[TBL] [Abstract][Full Text] [Related]
37. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
38. Generation of rabbit pluripotent stem cell lines.
Tancos Z; Nemes C; Polgar Z; Gocza E; Daniel N; Stout TA; Maraghechi P; Pirity MK; Osteil P; Tapponnier Y; Markossian S; Godet M; Afanassieff M; Bosze Z; Duranthon V; Savatier P; Dinnyes A
Theriogenology; 2012 Nov; 78(8):1774-86. PubMed ID: 22925641
[TBL] [Abstract][Full Text] [Related]
39. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.
Mandenius CF; Steel D; Noor F; Meyer T; Heinzle E; Asp J; Arain S; Kraushaar U; Bremer S; Class R; Sartipy P
J Appl Toxicol; 2011 Apr; 31(3):191-205. PubMed ID: 21328588
[TBL] [Abstract][Full Text] [Related]
40. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
Zhang XZ
Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
